M. Rostami-Yazdi

Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.

U. Mrowietz, S. Gerdes, R. Han, 2012, British journal of clinical pharmacology.

Leptin, adiponectin, visfatin and retinol‐binding protein‐4 – mediators of comorbidities in patients with psoriasis?

M. Weichenthal, U. Mrowietz, S. Gerdes, 2012, Experimental dermatology.

Adipokines and psoriasis

U. Mrowietz, S. Gerdes, M. Rostami-Yazdi, 2011, Experimental dermatology.

Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action.

U. Mrowietz, T. Schmidt, B. Clement, 2009, The Journal of investigative dermatology.

Oxidative stress in the pathogenesis of psoriasis.

U. Mrowietz, M. Rostami-Yazdi, Qiang Zhou, 2009, Free radical biology & medicine.

[15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris].

K. Reich, U. Mrowietz, M. Rostami-Yazdi, 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation

U. Mrowietz, H. Wilms, J. Sievers, 2010, Journal of Neuroinflammation.

Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients

U. Mrowietz, B. Clement, M. Rostami-Yazdi, 2010, Archives of Dermatological Research.

Detection of fumarate–glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism

T. Skak-Nielsen, U. Mrowietz, B. Clement, 2013, Archives of Dermatological Research.